The Aesthetics market is projected to grow at a steady pace driven by growing adoption of minimally invasive and noninvasive procedures, with 11-12% compound annual growth rate anticipated from 2020 to 2025.
We aim to make an impact in the lives of consumers by providing innovative and effective aesthetic solutions. We provide our customers with the treatments, services and education to help their clients achieve optimal results that enhance their skin and meet their individual needs.
We have decades of Aesthetics innovation and unique heritage in hyaluronic acid (HA) fillers and botulinum neuromodulators. Already established as one of the market’s leading companies, we are growing our comprehensive portfolio of recognized brands and services trusted by healthcare professionals and their clientele, including Dysport, Alluzience, Restylane and Sculptra.
A key pipeline project under investigation is RelabotulinumtoxinA, as a novel, ready-to-use, liquid formulation of botulinum neuromodulator for the treatment of glabellar lines and lateral canthal lines.